{"id":"781c29b1-c5f1-4341-808a-6b1f73582d58","kind":"institutions","code":"UB-I2378","name":"Chuangjing Capital","nameBasis":"transliterated","summary":"Chuangjing Capital is a mainland Chinese venture capital firm, focused on early-stage innovation projects.","description":"Chuangjing Capital is a mainland Chinese venture capital firm, focused on early-stage innovation projects.","country":null,"category":null,"originalName":"创景资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:36:31.031Z","englishUpdatedAt":"2026-10-15T18:43:03.680Z","reviewedAt":"2026-10-15T18:43:03.680Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"65a754d3fe5e3ef09a6e193b029044a4335a9fc03e7da2f8d932b279dd280edc","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"创景资本，一家中国大陆风险投资机构，侧重早期创新项目。","sources":[],"related":[{"id":"a1cb92c6-aefb-4cee-b4ae-d2749553b4a8","kind":"news","code":"a1cb92c6-aefb-4cee-b4ae-d2749553b4a8","name":"iRegene raises RMB 100 million in Series B financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"睿健医药完成1亿元B轮融资","eventDate":"2025-09-04T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-10T18:48:19.834Z","englishUpdatedAt":"2026-10-15T17:19:59.807Z","reviewedAt":"2026-10-15T17:19:59.807Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f53b92a2dfa97b78ead9f1687d7dff7d4a48c4b8c9f6be719aaa522f5ffcdce5","companyId":"c6f40f74-5248-4720-8404-fd1e03022e90","foundedYear":null,"logoUrl":null,"path":"/news/a1cb92c6-aefb-4cee-b4ae-d2749553b4a8"}],"path":"/institutions/chuangjing-capital","displayName":"创景资本","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"创景资本 is a venture capital investor based in China (mainland) with 1 recorded investment.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/chuangjing-capital"}